Aspergillus fumigatus
Jump to navigation
Jump to search
Etiology
- immunosuppression, including chemotherapy
Epidemiology
- in patients with AML & chemotherapy-induced neutropenia, Aspergillosis is far more common than blastomycosis, candidiasis, or Pneumocystis pneumonia[
Pathology
- invasive pulmonary aspergillosis
- begins in the respiratory tract, then enters the circulatory system, followed by formation of a fungus-septic emboli complex with subsequent hematogenous dissemination
- sinusitis, brain abscess, endocarditis, disseminated infection, & osteomyelitis also may occur
Laboratory
- Aspergillus fumigatus serology
- Aspergillus fumigatus antigen
- Aspergillus fumigatus DNA
- microscopy:
- methenamine silver stain
- acutely branching hyphae with septations
Differential diagnosis
- Pneumocystis jirovecii
- does not form hyphae
- appears as cysts or trophic forms
- often appears as foamy intra-alveolar exudates on methenamine silver stain
More general terms
References
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 20 American College of Physicians, Philadelphia 2025
- ↑ Godoy MCB, Ferreira Dalla Pria HR, Truong MT, Shroff GS, Marom EM. Invasive Fungal Pneumonia in Immunocompromised Patients. Radiol Clin North Am. 2022 May;60(3):497-506. PMID: https://pubmed.ncbi.nlm.nih.gov/35534133 Review.